Abbvie Inc. (abbv 3.2 11/21/29)
13F holders, Q2 2026 (June 30)1holders
1new positions
0sold out
$0.96avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Abbvie Inc. (abbv 3.2 11/21/29) in their 13F filings, unchanged from Q3 2025. 1 opened new positions and 0 sold out. The largest holder was Vermillion Wealth Management, Inc. ($17K).
- Company
- Abbvie Inc. (abbv 3.2 11/21/29)
- CUSIP
- 00287YBX6
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $17K |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q2 2026: 18,000 shares bought, net +18,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Vermillion Wealth Management, Inc. | 0.00% | New | 18,000 | $17K |
"% of holder's portfolio" is ABBVIE INC (ABBV 3.2 11/21/29)'s weight in each manager's 13F, not the share of Abbvie Inc. (abbv 3.2 11/21/29) the manager owns.